Edor Kabashi

Edor Kabashi is a leading researcher in translational neuroscience, specializing in genetic causes of neurological disorders such as Developmental and Epileptic Encephalopathy (DEE), Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), and Frontotemporal Dementia (FTD). His team at the Imagine Institute (Necker Hospital site) develops advanced cellular and zebrafish models to elucidate disease mechanisms and accelerate therapeutic validation. Key research areas include iPSC-derived neurons, drug screening platforms, and genomic sequencing analysis. Collaborations span national/international networks with institutions like ANR and pharmaceutical partners.

• Expertise: Genetic epilepsy, neurodegeneration, translational drug development
• Techniques: CRISPR gene editing, induced pluripotent stem cells, high-throughput screening

Current projects focus on fast-tracking neuroprotective compounds into clinical trials, leveraging state-of-the-art platforms such as transcriptomic/proteomic analysis and advanced imaging. Actively recruiting postdocs and PhD candidates with expertise in zebrafish models, molecular genetics, and bioinformatics.